Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

HIV Infection

Free Subscription 20.05.2024 5 AIDS 4 AIDS Res Hum Retroviruses 1 Ann Neurol 1 Antimicrob Agents Chemother 1 BMJ 6 Clin Infect Dis 5 HIV Med 1 J Clin Immunol 6 J Infect Dis 1 J Med Virol 1 JAMA 1 Pediatr Infect Dis J 8 PLoS One 1 PLoS Pathog 3 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. WEISER SD, Sheira LA, Weke E, Zakaras JM, et al
   An agricultural livelihood intervention is associated with reduced HIV stigma among people living with HIV.
   AIDS. 2024 May 16. doi: 10.1097/QAD.0000000000003928.
   PubMed         Abstract available
   
   
2. MATTHEWS LT, Jaggernath M, Kriel Y, Smith PM, et al
   Oral PrEP uptake, adherence, and persistence during periconception periods among women in South Africa: an intervention study.
   AIDS. 2024 May 15. doi: 10.1097/QAD.0000000000003925.
   PubMed         Abstract available
   
   
3. KELLY NK, Ranapurwala SI, Pence BW, Hightow-Weidman LB, et al
   The relationship between anti-LGBTQ+ legislation and HIV prevention among sexual and gender minoritized youth.
   AIDS. 2024 May 14. doi: 10.1097/QAD.0000000000003926.
   PubMed         Abstract available
   
   
4. XIA Q, Edelstein ZR, Katz B, Bertolino D, et al
   Impact of HIV pre-exposure prophylaxis prescriptions on HIV diagnoses in New York city.
   AIDS. 2024 May 14. doi: 10.1097/QAD.0000000000003927.
   PubMed         Abstract available
   
   
5. TRICKEY A, Zhang L, Rentsch CT, Pantazis N, et al
   Care interruptions and mortality among adults in Europe and North America: a collaborative analysis of cohort studies.
   AIDS. 2024 May 8. doi: 10.1097/QAD.0000000000003924.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

6. TAGLIAFERRI RAEL C, Giguere R, Bryndza Tfaily E, Sutton S, et al
   The Global Impact of Diversifying PrEP Options: Results of an International Discrete Choice Experiment of Existing and Potential PrEP Strategies with Gay and Bisexual Men (GBM) and Physicians.
   AIDS Res Hum Retroviruses. 2024 May 16. doi: 10.1089/AID.2023.0120.
   PubMed         Abstract available
   
   
7. MISHRA T, Phillips S, Maldonado C, Stapleton J, et al
   Antiretroviral therapy suppresses RNA N6-methyladenosine modification in peripheral blood mononuclear cells from HIV-1-infected individuals.
   AIDS Res Hum Retroviruses. 2024 May 16. doi: 10.1089/AID.2024.0003.
   PubMed         Abstract available
   
   
8. GUO L, Fu Y, Xie X, Yan W, et al
   Comparative on the Efficacy and Safety of ANV-Based Versus EFV-Based ART in the Management of Persons Living with HIV: A Real-World Study in Guizhou, China.
   AIDS Res Hum Retroviruses. 2024 May 16. doi: 10.1089/AID.2024.0030.
   PubMed         Abstract available
   
   
9. WOOLLEY G, Kroll K, Hoffman K, Ward A, et al
   The Climate Change Burden on Immune Health: Are Persons Living With HIV More at Risk?
   AIDS Res Hum Retroviruses. 2024 May 16. doi: 10.1089/AID.2024.0050.
   PubMed         Abstract available
   
   

   
   Ann Neurol

10. CHEN X, Wei J, Li Z, Zhang Y, et al
    Dysregulation of Gut Microbiota-Derived Neuromodulatory Amino Acid Metabolism in Human Immunodeficiency Virus-Associated Neurocognitive Disorder: An Integrative Metagenomic and Metabolomic Analysis.
    Ann Neurol. 2024 May 16. doi: 10.1002/ana.26963.
    PubMed         Abstract available
    
    

    
    Antimicrob Agents Chemother

11. BECKEN B, Dousa KM, Johnson JL, Holland SM, et al
    Dual beta-lactam for treatment of pulmonary Mycobacterium abscessus in a child.
    Antimicrob Agents Chemother. 2024 May 17:e0031924. doi: 10.1128/aac.00319.
    PubMed         Abstract available
    
    

    
    BMJ

12. FALCARO M, Soldan K, Ndlela B, Sasieni P, et al
    Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study.
    BMJ. 2024;385:e077341.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

13. BURKE RM, Nyirenda SK, Mtenga T, Twabi HH, et al
    Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial.
    Clin Infect Dis. 2024 May 15:ciae273. doi: 10.1093.
    PubMed         Abstract available
    
    
14. CARLUCCI JG, Huntington T, Technau KG, Yotebieng M, et al
    High Prevalence of Unconfirmed Positive HIV PCR Test Results among African Infants with HIV Exposure in the International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium.
    Clin Infect Dis. 2024 May 14:ciae251. doi: 10.1093.
    PubMed         Abstract available
    
    
15. SHAH NS, Kityo C, Hughes MD, McCarthy C, et al
    Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
    Clin Infect Dis. 2024 May 13:ciae269. doi: 10.1093.
    PubMed         Abstract available
    
    
16. UNIGWE I, Goodin A, Lo-Ciganic WH, Cook RL, et al
    Trajectories of Pre-exposure Prophylaxis Adherence Among Commercially Insured Individuals.
    Clin Infect Dis. 2024;78:1272-1275.
    PubMed         Abstract available
    
    
17. HERBERT C, Manabe YC, Filippaios A, Lin H, et al
    Differential Viral Dynamics by Sex and Body Mass Index During Acute SARS-CoV-2 Infection: Results from a Longitudinal Cohort Study.
    Clin Infect Dis. 2023 Nov 16:ciad701. doi: 10.1093.
    PubMed         Abstract available
    
    
18. KONU YR, Takassi E, Peytavin G, Dapam N, et al
    Pharmaco-virological outcomes and genotypic resistance profiles among children and adolescents receiving a DTG-based regimen in Togo.
    Clin Infect Dis. 2024 May 15:ciae278. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

19. NAKAMURA H, Yamamoto K
    Mpox in people with HIV: A narrative review.
    HIV Med. 2024 May 15. doi: 10.1111/hiv.13661.
    PubMed         Abstract available
    
    
20. BUSCA-ARENZANA C, Ortega-Gonzalez D, Diaz-Almiron M, Montes ML, et al
    Metabolic effects of switching to Biktarvy (B/F/TAF) in patients with HIV-1 treated with antiretroviral regimens that do not include tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF): The Metabic study.
    HIV Med. 2024 May 15. doi: 10.1111/hiv.13659.
    PubMed         Abstract available
    
    
21. LUMBRERAS ARETA M, Migliorelli Falcone FE, Rudin C, Kahlert CR, et al
    Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study.
    HIV Med. 2024 May 16. doi: 10.1111/hiv.13652.
    PubMed         Abstract available
    
    
22. LOGIE CH, Sokolovic N, Casale A, Ndung'u M, et al
    Clinical HIV outcome trajectories associated with a history of child protective service out-of-home care: Longitudinal cohort findings with women living with HIV in Canada.
    HIV Med. 2024 May 17. doi: 10.1111/hiv.13660.
    PubMed         Abstract available
    
    
23. KATLAMA C, Bisshop F, Bogner J, Perez Elias MJ, et al
    Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies.
    HIV Med. 2024 May 17. doi: 10.1111/hiv.13643.
    PubMed         Abstract available
    
    

    
    J Clin Immunol

24. GARDNER LS, Vaughan L, Avery DT, Meyts I, et al
    Development of EBV Related Diffuse Large B-cell Lymphoma in Deficiency of Adenosine Deaminase 2 with Uncontrolled EBV Infection.
    J Clin Immunol. 2024;44:118.
    PubMed         Abstract available
    
    

    
    J Infect Dis

25. MCCLUSKEY SM, Muyindike WR, Nanfuka V, Omoding D, et al
    Population Effectiveness of Dolutegravir Implementation in Uganda - A Prospective Observational Cohort Study (DISCO): 48-week Results.
    J Infect Dis. 2024 May 16:jiae260. doi: 10.1093.
    PubMed         Abstract available
    
    
26. SMITH CL, Didion E, Aung H, Tamilselvan B, et al
    Longitudinal analysis of nursing home residents' T cell responses after SARS-CoV-2 mRNA vaccinations shows influence of biological sex and SARS-CoV-2 infection history.
    J Infect Dis. 2024 May 14:jiae234. doi: 10.1093.
    PubMed         Abstract available
    
    
27. MASIA M, Garcia JA, Garcia-Abellan J, Padilla S, et al
    Distinct gut microbiota signatures associated with progression of atherosclerosis in people living with HIV.
    J Infect Dis. 2024 May 14:jiae243. doi: 10.1093.
    PubMed         Abstract available
    
    
28. MOTSOENENG BM, Dhar N, Nunes MC, Krammer F, et al
    Hemagglutinin stalk-specific Fc-mediated functions are associated with protection against influenza-illness after seasonal influenza vaccination in pregnant women.
    J Infect Dis. 2024 May 14:jiae241. doi: 10.1093.
    PubMed         Abstract available
    
    
29. SERRANO-VILLAR S, Martinez E
    The Gut Microbiome: Another Piece in the Puzzle of HIV-Associated Atherosclerosis.
    J Infect Dis. 2024 May 14:jiae244. doi: 10.1093.
    PubMed        
    
    
30. PATHELA P, Townsend MB, Kopping EJ, Tang J, et al
    Serological Evidence of Mpox Virus Infection During Peak Mpox Transmission in New York City, July to August 2022.
    J Infect Dis. 2024 May 13:jiae181. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

31. HWANG JH, Hwang JH
    Is a 2-week regimen of tecovirimat sufficient for the treatment of Mpox (monkeypox) in advanced HIV patients with a low CD4 cell count?
    J Med Virol. 2024;96:e29617.
    PubMed        
    
    

    
    JAMA

32. MCKENNA M
    Produce Prescriptions Sound Good, but Data to Support Them Are Lacking-That Could Soon Change.
    JAMA. 2024;331:1433-1436.
    PubMed        
    
    

    
    Pediatr Infect Dis J

33. KENNEALLY AM, Bates BN
    Accidental Raltegravir Overdose in a Neonate: Case Report and Review of Literature.
    Pediatr Infect Dis J. 2024 Feb 6. doi: 10.1097/INF.0000000000004273.
    PubMed        
    
    

    
    PLoS One

34. KIM GS, Kim L, Lee S, Shim MS, et al
    Factors associated with health-related quality of life among people living with HIV in South Korea: Tobit regression analysis.
    PLoS One. 2024;19:e0303568.
    PubMed         Abstract available
    
    
35. HAGOS YM, Yalew GT, Meles HN, Tsegay E, et al
    Hepatitis B and C viral coinfection and associated factors among HIV-positive patients attending ART clinics of Afar regional state, northeast Ethiopia.
    PLoS One. 2024;19:e0302453.
    PubMed         Abstract available
    
    
36. KHEZRI M, McKnight C, Weng CA, Kimball S, et al
    COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City.
    PLoS One. 2024;19:e0303394.
    PubMed         Abstract available
    
    
37. OPITO R, Kwenya K, Ssentongo SM, Kizito M, et al
    Treatment success rate and associated factors among drug susceptible tuberculosis individuals in St. Kizito Hospital, Matany, Napak district, Karamoja region. A retrospective study.
    PLoS One. 2024;19:e0300916.
    PubMed         Abstract available
    
    
38. NIEMCZAK CE, Montagnese B, Levy J, Fellows AM, et al
    Machine learning for predicting cognitive deficits using auditory and demographic factors.
    PLoS One. 2024;19:e0302902.
    PubMed         Abstract available
    
    
39. PACK AP, Masters MC, O'Conor R, Alcantara K, et al
    Patient and clinician preferences for diabetes management among older adults with co-morbid HIV: A qualitative exploration.
    PLoS One. 2024;19:e0303499.
    PubMed         Abstract available
    
    
40. BELETE MB, Bitew A, Mulatu K
    Viral load suppression and its predictor among HIV seropositive people who receive enhanced adherence counseling at public health institutions in Bahir Dar, Northwest Ethiopia. Retrospective follow-up study.
    PLoS One. 2024;19:e0303243.
    PubMed         Abstract available
    
    
41. OSAYI EO, Ajayi O, Onyeji J, Isichei M, et al
    The prevalence of internalized stigma and its association with HIV viral suppression among fully disclosed adolescents and young adults living with HIV (AYLHIV) receiving HIV care in an HIV clinic in Plateau State, Nigeria.
    PLoS One. 2024;19:e0303360.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

42. AMORIM SACRAMENTO L, Farias Amorim C, G Lombana C, Beiting D, et al
    CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions.
    PLoS Pathog. 2024;20:e1012211.
    PubMed         Abstract available
    
    

    
    Science

43. STEICHEN JM, Phung I, Salcedo E, Ozorowski G, et al
    Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates.
    Science. 2024;384:eadj8321.
    PubMed         Abstract available
    
    
44. XIE Z, Lin YC, Steichen JM, Ozorowski G, et al
    mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies.
    Science. 2024;384:eadk0582.
    PubMed         Abstract available
    
    
45. SANDERS RW, Moore JP
    Progress on priming HIV-1 immunity.
    Science. 2024;384:738-739.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.